Drug heart stents more likely to clot blood
Data released a week prior to FDA meeting to discuss risk from devices
NBC VIDEO |
Heart stents causing problems for some patients Nov. 28: Millions of Americans could be walking around with tiny time bombs in their hearts. NBC's Robert Bazell reports. Nightly News |
CHICAGO - Blood clotting is four to five times more likely in patients getting drug-coated heart devices known as stents, compared to the older bare-metal variety, according to a large data analysis released Wednesday.
The analysis came one week before a Food and Drug Administration panel of experts is to meet to discuss the issue.
The Cleveland Clinic analysis of 14 studies with 6,675 patients will likely fuel a growing debate about the safety of drug-coated stents, the tiny wire-mesh devices used to prop open surgically cleared arteries.
Thrombosis, or blood clots, can lead to heart attacks.
The release of the study in the December issue of American Journal of Medicine came one week before the FDA panel is to discuss stent thrombosis, or potentially fatal blood clotting long after the devices are implanted.
Click for related content |
“Our analysis found that there is a small, but real hazard of late stent thrombosis with drug-eluting stents more so than with bare-metal stents, likely in the setting of discontinuation of anti-clotting drugs,” said Dr. Deepak Bhatt, a Cleveland Clinic official, in a prepared statement.
“This does not mean that drug-eluting stents should not be used, as other studies have shown that they do significantly reduce the need for repeat procedures compared with bare metal stents,” added Bhatt, associate director of the Cleveland Clinic Cardiovascular Coordinating Center and one of the study’s authors.
- Discuss Story On Newsvine
- Rate Story:
View popularLowHigh - Instant Message
MORE FROM HEART HEALTH |
| Add Heart health headlines to your news reader: |


